Companies / Dogwood Therapeutics, Inc. / Activity
Activity — Dogwood Therapeutics, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $132.2K | +63K +373.41% | 79,434 0.24% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $45.9K | +29K +95053.33% | 28,546 0.08% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $39.1K | +9K +58743.75% | 9,415 0.03% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | Common Stock | $213 | +101 +0.87% | 11,756 0.03% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | New | Common Stock | $39 | +5 | 5 <0.01% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Exit | Common Stock | $-39 | -5 -100.00% | 0 | low |